Meet Jessica Karz, our Senior R&D Engineer! This next year, Jessica will celebrate an incredible 10 years with our team. As Fluidx has grown, Jessica has had the opportunity to wear many hats throughout her career.
We’re grateful for everything Jessica brings to the team.
Fluidx Medical Technology is the @UniversityOfUtah Startup of the Year. 🏆
We were recognized for completing the pivotal IDE trial and PMA submission for GPX and for advancing the ULTRA and IMPASS products through key milestones.
Thank you @UTechLicensing#Innovation#IR
When the first case of the day goes longer than scheduled and the next patient is on the table already, is the #embolic ready? With its fast prep and no extra vials or mixing stations, GPX was designed to be ready when the physician is.
#IR#Embolization#InterventionalRadiology
🔵 Come learn about the GPX pivotal trial results in Copenhagen at #CIRSE2026!
Join us Monday, September 7 at 17:30 in Rm19 for the oral presentation Results from the GPX IDE pivotal clinical trial by Dr. Andrew Holden.
#IR#Embolization#InterventionalRadiology#Embolotherapy
At Fluidx, we're dedicated to advancing the science of #embolization across a wide range of diseases. Drug release from ionic gel #embolics, and its potential to enable improved and differentiated embolization outcomes, is an area of research we're excited to pioneer. #IR#RCC
At #Fluidx, our mission is to develop a new, innovative category of easy to use, controllable #embolic gels that can treat the widest range of clinical conditions, effectively occluding the smallest vessels up to the largest vessels. #IR#embolotherapy#interventionalradiology
At #Fluidx, our mission is to develop a new, innovative category of easy to use, controllable #embolic gels that can treat the widest range of clinical conditions, effectively occluding the smallest vessels up to the largest vessels. #IR#embolotherapy#interventionalradiology
We are pleased to welcome Larry Kronick to the Board of Directors. Larry has been involved with Fluidx since its founding and has extensive operational and commercial experience in the interventional space.
This discussion about liquid embolics with Dr. Siskin on clinical applications and technical considerations is a useful primer for anyone working in #embolization.
https://t.co/QDHldxwDE8
Come see our poster 193 at #SNIS 2026 (July 20–24) where we present preclinical work on a liquid embolic engineered for temporary radiopacity — visible during delivery, out of the way for follow-up imaging. #Embolization#Neurosurgery#Neurovascular
We are pleased to report continued clinical success with the ULTRA Embolic Device, a novel gel embolic in development for #embolization to control bleeding in the peripheral vasculature and embolization of hypervascular #tumors.
#IR#embolotherapy
https://t.co/DoR3SR93Nw
ULTRA: a first-of-its-kind embolic gel engineered for consistent, fast, complete occlusions. This delivery video of ULTRA shows the visibility, control, and immediate occlusion — without adhering to the delivery microcatheter.
#embolization#hemorrhage#peripheralvascular#IR
Coils and plugs require time-consuming and unreliable clot formation to create a full occlusion. In a fully heparinized preclinical model, ULTRA demonstrated immediate occlusion of the GDA delivered behind a vascular plug. #embolization#hemorrhage#peripheralvascular#IR
Why is a distal flowing neurovascular embolic differentiated? Current solutions do not readily flow to the end of the vessel. Dilutions, wedging and various techniques are used to to deliver material distally which has been shown to result in faster resolution of the hematoma.
We wanted to give physicians one thing they could count on, regardless of what the case brought. ULTRA is designed to have excellent fluoroscopic visibility and consistent, technique-independent performance across a variety of anatomies.
#InterventionalRadiology#MedTech
Every peripheral #embolization case brings something new — a different anatomy, a different patient, a different challenge.
That variability is part of what makes interventional radiology demanding. It's also what drove us at Fluidx when we set out to build ULTRA.